
Sputnik Light nod set to boost vaccine’s demand
The Hindu
Role of two-dose Sputnik V vaccine in India’s inoculation programme, thus far, has been limited for multiple reasons
The Drugs Controller General of India (DCGI)‘s approval to the single-shot Sputnik Light for restricted use in emergency situations is likely to boost demand for the Russian vaccine in the country.
Union Health Minister Mansukh Mandaviya on Sunday evening tweeted “DCGI has granted emergency use permission to single-dose Sputnik Light... this is the 9th COVID19 vaccine in the country,” while pharma major Dr. Reddy’s Laboratories confirmed the development in a statement on Monday.
Sputnik Light is the same as the first component — recombinant human adenovirus serotype number 26 (rAd26 ) — of the two-dose Sputnik V vaccine, whose role in India’s inoculation programme thus far had been limited, for multiple reasons, including those related to its supplies. Also, the two-dose Sputnik has been administered mostly through private hospitals.